These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 23348972

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
    Wilson CB, Jones PW, O'Leary CJ, Hansell DM, Cole PJ, Wilson R.
    Eur Respir J; 1997 Aug; 10(8):1754-60. PubMed ID: 9272915
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities.
    van der Gast CJ, Walker AW, Stressmann FA, Rogers GB, Scott P, Daniels TW, Carroll MP, Parkhill J, Bruce KD.
    ISME J; 2011 May; 5(5):780-91. PubMed ID: 21151003
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
    Fjaellegaard K, Sin MD, Browatzki A, Ulrik CS.
    Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection.
    VanDevanter DR, Gonda I, Dahms J, Cipolla D, Davis AM, Chalmers JD, Froehlich J.
    Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
    Li W, Wang B, Tan M, Song X, Xie S, Wang C.
    Respir Res; 2022 Nov 19; 23(1):321. PubMed ID: 36403054
    [Abstract] [Full Text] [Related]

  • 36. Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.
    Burr LD, Rogers GB, Chen AC, Hamilton BR, Pool GF, Taylor SL, Venter D, Bowler SD, Biga S, McGuckin MA.
    Ann Am Thorac Soc; 2016 Oct 19; 13(10):1697-1703. PubMed ID: 27464029
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Altered community compositions of Proteobacteria in adults with bronchiectasis.
    Guan WJ, Yuan JJ, Li HM, Gao YH, Chen CL, Huang Y, Chen RC, Zhong NS.
    Int J Chron Obstruct Pulmon Dis; 2018 Oct 19; 13():2173-2182. PubMed ID: 30140149
    [Abstract] [Full Text] [Related]

  • 39. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
    Taylor SL, Rogers GB, Chen AC, Burr LD, McGuckin MA, Serisier DJ.
    Ann Am Thorac Soc; 2015 May 19; 12(5):701-7. PubMed ID: 25679336
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.